https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Patients with sickle cell disease (SCD) experience high rates of chronic pain, and have a high burden of mental health comorbidities shown to negatively influence health. There is limited research on substance use among individuals with SCD. The aim of this study is to measure the prevalence of substance use in patients with SCD and determine whether psychosocial or clinical risk factors are associated with substance use. This study was conducted as part of an observational study of patients with SCD at two academic medical centers. W
Like
Comment
Share
